Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Enterobacteria phage Ly1

Known as: Bacteriophage Ly1 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract 2058: BCL-2 selective inhibitor APG-2575 synergizes with BTK inhibitor in preclinical xenograft models of follicular lymphoma and diffuse large B-cell lymphoma
Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are among the most prevalent B-lymphocyte neoplasms with… Expand
2019
2019
Abstract 4825: Preclinical characterization of BAY-924, a first in class ADC targeting CXCR5-positive B-cell malignancies, with a KSP inhibitor as novel payload
Despite recent progress in the treatment of B-cell malignancies, patients are still in need of innovative therapeutic approaches… Expand
2019
2019
Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy.
We attempted to explore novel treatment options for progressive diffuse large B-cell lymphoma (DLBCL) with TP53 mutation that has… Expand
2018
2018
[Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
  • X. Zhang, Z. Ma, +5 authors X. Li
  • Zhonghua bing li xue za zhi = Chinese journal of…
  • 2018
    • Corpus ID: 26264041
Objective: To investigate the role of PRDM1 gene inactivaion in the regulation of C-MYC in diffuse large B-cell lymphoma (DLBCL… Expand
2017
2017
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs
Histone methylation and demethylation regulate B-cell development, and their deregulation correlates with tumor chemoresistance… Expand
  • table 1
2017
2017
PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro
PIK3CA has been extensively investigated from its molecular mechanism perspective and epidemiological association with its… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2016
2016
Abstract 306: Analysis of differentially expressed exosomal genes from ibrutinib resistant diffuse large B cell lymphoma
Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL) and approximately 30% of the… Expand
2013
2013
CXC chemokine ligand 16, inversely correlated with CD99 expression in Hodgkin Reed-Sternberg cells, is widely expressed in diverse types of lymphomas.
The present study examined a correlation between CXC chemokine ligand 16 (CXCL16) and cell differentiation antigen 99 (CD99… Expand
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Highly Cited
2010
Highly Cited
2010
Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin
Follicular lymphoma (FL) and the GCB subtype of diffuse large B-cell lymphoma (DLBCL) derive from germinal center B cells… Expand
  • figure 1
  • figure 2
  • table 1
  • table 3
1991
1991
Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of the T cell lymphoma EL4.
Yttrium-90 is a potent beta-emitting radionuclide with potential for therapy of lymphoma. A monoclonal antibody against Ly1, the… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE